James P Mackin Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 14 hours ago
James P Mackin has an estimated net worth of at least $28.9 million*, as of March 26, 2025. They own 865,283 shares of AORT stock. They have sold 384,482 shares of AORT stock since 2021, for an estimated $7.6 million.
James P Mackin $AORT SEC Form 4 Insider Trading
James P Mackin has filed a total of 21 insider trades in $AORT since 2021. Their most recent trade was a sale of 17,739 shares, made on Mar 06, 2025. Their largest trade was a sale of 70,700 shares, made on Mar 06, 2025. We estimate that they now own 865,283 shares of $AORT, worth an estimated $21.3 million.
Insider Trading at $AORT
There have been a total of 143 insider trades reported at $AORT since 2021, with 0 shares purchased and 729,852 shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, James P Mackin, and Amy Horton. The most recent trade was a sale of 18,020 shares reported by Jean F Holloway (SVP, General Counsel), made on Mar 11, 2025.
History of Insider Stock Trades by James P Mackin
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AORT
|
Sale | 17,739 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
AORT
|
Sale | 70,700 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
AORT
|
Sale | 16,664 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 13,784 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 6,812 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 4,896 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
AORT
|
Sale | 13,996 | Mar 05, 2024 | March 7, 2024, 7:20 p.m. |
|
AORT
|
Sale | 4,837 | Feb 27, 2024 | Feb. 29, 2024, 6:36 p.m. |
|
AORT
|
Sale | 13,168 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
AORT
|
Sale | 18,144 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
AORT
|
Sale | 2,756 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 59,225 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 10,088 | Feb 20, 2024 | Feb. 22, 2024, 6:08 p.m. |
|
AORT
|
Sale | 9,990 | Mar 02, 2023 | March 3, 2023, 7:07 p.m. |
|
AORT
|
Sale | 12,645 | Feb 27, 2023 | March 1, 2023, 2:36 p.m. |
|
AORT
|
Sale | 9,985 | Feb 27, 2023 | March 1, 2023, 2:36 p.m. |
|
AORT
|
Sale | 56,500 | Feb 14, 2023 | Feb. 16, 2023, 6:36 p.m. |
|
AORT
|
Sale | 10,638 | Feb 09, 2022 | Feb. 11, 2022, 9:41 a.m. |
|
AORT
|
Sale | 10,639 | Feb 10, 2022 | Feb. 11, 2022, 9:41 a.m. |
|
AORT
|
Sale | 10,638 | Feb 08, 2022 | Feb. 10, 2022, 8:53 a.m. |
|
AORT
|
Sale | 10,638 | Feb 07, 2022 | Feb. 8, 2022, 5:38 p.m. |
$AORT Executives and Stock Owners with Insider Trades
-
Jean F Holloway, SVP, General Counsel
-
James P Mackin, President & CEO
-
Amy Horton, VP, Chief Accounting Officer
-
Marshall S. Stanton, SVP, Clinical & MD Affair
-
Matthew A Getz, VP, Human Resources
-
Andrew M Green, VP Regulatory
-
Dennis B Maier, SVP, Operations
-
John E Davis, Chief Commercial Officer
-
Rochelle L. Maney, VP, Quality
-
David Ashley Lee, Executive VP, COO & CFO
-
John E Davis, Senior VP, Global Sales
-
Florian Tyrs, VP, Global Operations
-
Lance A Berry, Executive VP, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.